Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors.

Seminars in oncology nursing - 1 Oct 2024

Hsiao Chao-Pin, Goto Taichi, Von Ah Diane, Saligan Leorey N

Abstract excerpt

OBJECTIVES: Cancer-related cognitive impairment (CRCI) is a highly prevalent and debilitating symptom reported by breast cancer survivors (BCS). The etiology of CRCI remains unclear, leading to poor symptom management. Building from prior studies, BCS with the C/C genotype of apolipoprotein E (APOE) rs7412 and the T/T genotype of brain-derived neurotrophic factor (BDNF) rs6265 were hypothesized to experience more...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Apolipoproteins E

Share to Brain-Derived Neurotrophic Factor

Share to Breast Neoplasms

Share to Cancer Survivors

Share to Cognitive Dysfunction

Share to Cross-Sectional Studies

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 39198096
DOI: 10.1016/j.soncn.2024.151721

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer-Related Cognitive Impairment Associated with APOE rs7412 and BDNF rs6265 in Breast Cancer Survivors.PMID 39198096Read ↗

Associations of brain-derived neurotrophic factor rs6265 polymorphism and cognitive function in breast cancer survivors from a cross-sectional study.Semantic proximity Read ↗

Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.Semantic proximity Read ↗

Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.Semantic proximity Read ↗

Self-Reported Cancer-Related Cognitive Impairment in Patients With Breast Cancer Is Associated With Potassium Channel Gene Polymorphisms.Semantic proximity Read ↗

Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.Semantic proximity Read ↗

Protective Effects of APOE ε2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study.Semantic proximity Read ↗

A Systematic Review Focusing on Understanding the Effects of a Defined Set of Non-Modifiable Factors in Patients who Suffer from Chemotherapy Induced Cognitive Impairments or “Chemobrain”Semantic proximity Read ↗

Comparative Analysis of the Chemotherapy-related Cognitive Impairments in Patients with Breast Cancer: a Community-based ResearchSemantic proximity Read ↗

The Impact of APOE and Smoking History on Cognitive Function in Older, Long-Term Breast Cancer SurvivorsSemantic proximity Read ↗

The impact of APOE and smoking history on cognitive function in older, long-term breast cancer survivors.Semantic proximity Read ↗

Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy-related cognitive impairment in patients with breast cancer who receive chemotherapy.Semantic proximity Read ↗

Exploratory Study of Associations Between DNA Repair and Oxidative Stress Gene Polymorphisms and Cognitive Problems Reported by Postmenopausal Women With and Without Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.